Jaclyn st Louis

Jaclyn St Louis is an experienced professional in program management within the biotechnology and pharmaceutical sectors, currently serving as Director of Program and Portfolio Management at Eli Lilly and Company since October 2025. Prior roles include Director of Program Management and Associate Director of Program and Alliance Management at Verve Therapeutics, and Senior Manager of Program and Portfolio Management at Vertex Pharmaceuticals. Jaclyn's earlier experience includes managerial positions at CRISPR Therapeutics, where development and optimization of CRISPR/Cas9-mediated assays were key responsibilities, as well as roles at WuXi AppTec, The Children's Hospital of Philadelphia, and the University of Pennsylvania School of Medicine, focusing on various research projects related to gene editing, pediatric oncology, and psychiatric illnesses. Jaclyn completed a Master of Science in Pharmacology at the University of Pennsylvania and holds a Bachelor of Arts in Biotechnology and Chemistry from Assumption University.